Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-14

Clinical Trial Update: Preliminary Clinical Study on the Effect of Bacillus Subtilis on the Efficacy of Infliximab in Patients With Crohn's Disease [NA]

View source ↗

Summary

A preliminary clinical study is evaluating whether the probiotic Bacillus subtilis can influence the efficacy of infliximab in Crohn's disease; the trial is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bacillus subtilis (Bacillus subtilis)
  • Infliximab (infliximab)

Snippet

Sponsor: The Third Xiangya Hospital of Central South University | Conditions: Mild to Severe Crohns Disease | NA | Status: RECRUITING